Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma

Clinical trial NCT00630409 · COMPLETED

Trial details

NCT number: NCT00630409
Sponsor: University of Pittsburgh
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2004-09-01
Primary completion: 2009-09-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.